John D. Chovan, James R. Cacchillo
Insulin Resistance, Oral Hypoglycemic Medications
Endocrine System Diseases | Medical Pathology | Medicine and Health Sciences | Nursing
Approximately 28.9 million Americans have been diagnosed with type II diabetes (Jia-Haur Hu, Lin, Miller, Nguyen, & Nguyen, 2014). It is a disease that can cause or potentiate numerous comorbidities that negatively affects multiple body systems if left untreated (Jia-Haur Hu, et al., 2014). In 2012, the total estimated cost for treatment of type II diabetes in America was an astronomical $245 billion (Jia-Haur Hu, et al., 2014). Type II diabetes is a result of many cellular processes that lead to insulin resistance resulting in increased blood glucose levels (Jia-Haur Hu, et al., 2014). Treatments for type II diabetes include several different classifications of oral hypoglycemic medications, insulin injections, exercise, and a modified diet (Jia-Haur Hu, et al., 2014). With the number of Americans being diagnosed with type II diabetes on the rise, a strong understanding of the pathophysiology of the disease and its treatments cannot be disregarded.
Mountain, Gregory, "Type II Diabetes and its Treatment" (2015). Master of Science in Nursing (MSN) Student Scholarship. Paper 81.